EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Repurposing Metformin to Promote Fracture Callus Maturation via AMPK‐Driven Metabolic Activation

Vasyl Pastukh iD, Jianying Zhang iD, Peter G Alexander iD, Satyaj Bhargava iD, Arshia Shams iD, Celina Zhao iD, MaCalus V Hogan iD, James H-C Wang iD

Journal of Orthopaedic Research · 2026-07 · 44 (7)

DOI: 10.1002/jor.70246 ↗

At a glance

Journal article in Journal of Orthopaedic Research, published online on 2026-07-04. Written by Vasyl Pastukh and 7 co-authors. Institution: MechanoBiology Laboratory, Bethel Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pi…. Major MEDLINE topics: Metformin, AMP-Activated Protein Kinases, Fracture Healing, Femoral Fractures. 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Technology Enterprise Consortium, U.S. Department of Defense.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Femoral shaft fractures cause prolonged disability, and therapies that accelerate bone repair remain limited. Repurposing clinically approved drugs that target biological bottlenecks in healing is a promising strategy. This study investigated whether systemic metformin administration, an anti‐diabetic medication with known metabolic regulatory effects, enhances fracture repair in a rat open femoral shaft fracture model. Histological, immunofluorescent, micro‐CT, and biomechanical analyses were performed at 6 weeks post‐injury comparing metformin‐treated and vehicle‐treated animals. Metformin markedly accelerated callus maturation, evidenced by earlier hyaline cartilage ossification, increased collagen I deposition and fiber organization, and reduced collagen II and III expression compared with controls. Micro‐CT analysis demonstrated increased tissue mineral density, trabecular thickness, and bone volume fraction along with reduced connectivity density, indicating more advanced structural consolidation of the callus. Although biomechanical parameters were not significantly different at intermediate time point, ultimate load and stiffness trended higher in metformin‐treated animals, consistent with structural advancement. Mechanistically, metformin increased p‐AMPK expression, elevated mitochondrial markers (NDUFB8, TFAM), and reduced extracellular HMGB1 release, suggesting enhanced metabolic capacity and attenuated inflammatory stress during repair. Importantly, metformin's effects were most pronounced during the cartilage‐to‐bone transition phase, supporting a role for metabolic activation in promoting endochondral ossification. Together, these findings demonstrate that systemic metformin administration promotes earlier structural consolidation of the fracture callus through coordinated metabolic and inflammatory modulation, supporting the potential repurposing of this safe and inexpensive drug as an adjunct strategy to enhance bone repair.

Subjects

MeSH terms (MEDLINE)

MetforminAMP-Activated Protein KinasesFracture HealingFemoral FracturesBony CallusDrug RepositioningHypoglycemic AgentsAnimalsMaleRatsRats, Sprague-Dawley

Author keywords

AMPK signalingdrug repurposingendochondral ossificationfracture repairmitochondrial biogenesis

Substances

MetforminAMP-Activated Protein KinasesHypoglycemic Agents

Authors and institutions

  • MechanoBiology Laboratory, Bethel Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Joint Tissue Development and Engineering Laboratory, Bethel Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID profiles: Vasyl Pastukh, Jianying Zhang, Peter G Alexander, Satyaj Bhargava, Arshia Shams, Celina Zhao, MaCalus V Hogan, James H-C Wang

Funding

  • Medical Technology Enterprise Consortium
  • U.S. Department of Defense

Cite

APA

Pastukh, V., Zhang, J., Alexander, P. G., Bhargava, S., Shams, A., Zhao, C., Hogan, M. V., & Wang, J. H. (2026). Repurposing Metformin to Promote Fracture Callus Maturation via AMPK‐Driven Metabolic Activation. Journal of Orthopaedic Research, 44(7). https://doi.org/10.1002/jor.70246

Vancouver

Pastukh V, Zhang J, Alexander PG, Bhargava S, Shams A, Zhao C, et al. Repurposing Metformin to Promote Fracture Callus Maturation via AMPK‐Driven Metabolic Activation. Journal of Orthopaedic Research. 2026;44(7). doi:10.1002/jor.70246

BibTeX
@article{Pastukh2026,
  author = {Pastukh, Vasyl and Zhang, Jianying and Alexander, Peter G and Bhargava, Satyaj and Shams, Arshia and Zhao, Celina and Hogan, MaCalus V and Wang, James H-C},
  title = {Repurposing Metformin to Promote Fracture Callus Maturation via AMPK‐Driven Metabolic Activation},
  journal = {Journal of Orthopaedic Research},
  year = {2026},
  volume = {44},
  number = {7},
  doi = {10.1002/jor.70246}
}
Start for free →